Clinical Trials · NCT03631186
A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Switzerland, as Part of Local Clinical Practice (SURE SWITZERLAND)
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 215
- Start date
- Sep 2018
- Locations
- 28 sites, Switzerland
- Primary endpoint
- Change in Glycated Haemoglobin A1c (HbA1c)